ELV stock verdict - Avoid
ELV
ELEVANCE HEALTH, INC.
AVOIDHealthcare
$396.09
Fundamentals below bar
$396.09
Heavy$378.34Buy$459.41Fair$540.48Exit$594.53
VALUE39
GROWTH33
QUALITY54
TECHNICAL—
TRUST SCORE
93High
confidence in this read — data completeness, earnings quality & coverage
Technicals: insufficient price history
PROS
- Trades 27% below the model's fair value ($540.48)
- Reasonable forward P/E of 13.4× on analyst estimates
- Balance sheet holds net cash (cash exceeds total debt)
CONS
- Rich for its growth rate (PEG 9.6)
- TTM EPS fell 1.8% year-over-year
- Thin net margin of 3.2% (3-yr avg)
✳ Pros and cons are machine-generated from the latest fundamentals and technicals.
EARNINGS QUALITY · we check the accounting so you don't have to
✓Operating cash flow is 150% of net income — profit is backed by real cash
Analysis as of 2026-09-25 · price live, fundamentals from latest filings
Congress Trading — last 90 days
See what senators are buying and selling on ELV. Sign in to unlock.
📊 Options Flow — Put/Call Ratio
FAQ
Why is ELV rated Avoid?
ELV (ELEVANCE HEALTH, INC.) is rated Avoid because the model combines fundamentals, price action, and earnings-quality checks. The current signal is Fundamentals below bar. Trades 27% below the model's fair value ($540.48) and Reasonable forward P/E of 13.4× on analyst estimates
Is ELV overvalued right now?
ELV is trading at $396.09 versus an estimated fair value of $540.48. That puts the stock in avoid territory on this framework. Rich for its growth rate (PEG 9.6) and TTM EPS fell 1.8% year-over-year
What should I watch before acting on ELV?
Watch the trust score of 93, the earnings-quality checks, and any red flags. Rich for its growth rate (PEG 9.6) and TTM EPS fell 1.8% year-over-year